I M Lipkus, D Iden, J Terrenoire, J R Feaganes. Cancer Epidemiol Biomarkers Prev 1999
Times Cited: 105
Times Cited: 105
Times Cited
Times Co-cited
Similarity
Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
34
Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
25
Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population.
E S Tambor, B K Rimer, T S Strigo. Am J Med Genet 1997
E S Tambor, B K Rimer, T S Strigo. Am J Med Genet 1997
23
Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample.
K A Donovan, D C Tucker. J Behav Med 2000
K A Donovan, D C Tucker. J Behav Med 2000
25
Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
22
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
21
Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.
C Lerman, C Hughes, J L Benkendorf, B Biesecker, J Kerner, J Willison, N Eads, D Hadley, J Lynch. Cancer Epidemiol Biomarkers Prev 1999
C Lerman, C Hughes, J L Benkendorf, B Biesecker, J Kerner, J Willison, N Eads, D Hadley, J Lynch. Cancer Epidemiol Biomarkers Prev 1999
20
Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
19
Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation.
A Y Kinney, R T Croyle, W N Dudley, C A Bailey, M K Pelias, S L Neuhausen. Prev Med 2001
A Y Kinney, R T Croyle, W N Dudley, C A Bailey, M K Pelias, S L Neuhausen. Prev Med 2001
26
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
17
Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
16
Interest in learning of personal genetic risk for cancer: a general population survey.
M A Andrykowski, R K Munn, J L Studts. Prev Med 1996
M A Andrykowski, R K Munn, J L Studts. Prev Med 1996
15
What is the relationship between breast cancer risk and mammography screening? A meta-analytic review.
K D McCaul, A D Branstetter, D M Schroeder, R E Glasgow. Health Psychol 1996
K D McCaul, A D Branstetter, D M Schroeder, R E Glasgow. Health Psychol 1996
14
Ethnic differences in risk perception among women at increased risk for breast cancer.
C Hughes, C Lerman, E Lustbader. Breast Cancer Res Treat 1996
C Hughes, C Lerman, E Lustbader. Breast Cancer Res Treat 1996
13
Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
13
Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations.
N A Press, Y Yasui, S Reynolds, S J Durfy, W Burke. Am J Med Genet 2001
N A Press, Y Yasui, S Reynolds, S J Durfy, W Burke. Am J Med Genet 2001
16
Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
13
Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
12
Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
19
Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
12
Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.
K Glanz, J Grove, C Lerman, C Gotay, L Le Marchand. Cancer Epidemiol Biomarkers Prev 1999
K Glanz, J Grove, C Lerman, C Gotay, L Le Marchand. Cancer Epidemiol Biomarkers Prev 1999
12
Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
11
Interest in BRCA1/2 testing in a primary care population.
Katrina Armstrong, Barbara Weber, Peter A Ubel, Carmen Guerra, J Sanford Schwartz. Prev Med 2002
Katrina Armstrong, Barbara Weber, Peter A Ubel, Carmen Guerra, J Sanford Schwartz. Prev Med 2002
20
Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer.
M A Diefenbach, S M Miller, M B Daly. Health Psychol 1999
M A Diefenbach, S M Miller, M B Daly. Health Psychol 1999
11
Awareness and attitudes concerning BRCA gene testing.
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
20
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
10
The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
10
Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
10
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
10
Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
10
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer.
O Bratt, J E Damber, M Emanuelsson, U Kristoffersson, R Lundgren, H Olsson, H Grönberg. Eur J Cancer 2000
O Bratt, J E Damber, M Emanuelsson, U Kristoffersson, R Lundgren, H Olsson, H Grönberg. Eur J Cancer 2000
10
Spiritual faith and genetic testing decisions among high-risk breast cancer probands.
M D Schwartz, C Hughes, J Roth, D Main, B N Peshkin, C Isaacs, C Kavanagh, C Lerman. Cancer Epidemiol Biomarkers Prev 2000
M D Schwartz, C Hughes, J Roth, D Main, B N Peshkin, C Isaacs, C Kavanagh, C Lerman. Cancer Epidemiol Biomarkers Prev 2000
11
Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
9
Psychological distress and surveillance behaviors of women with a family history of breast cancer.
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
9
Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer.
Q Gao, G Tomlinson, S Das, S Cummings, L Sveen, J Fackenthal, P Schumm, O I Olopade. Hum Genet 2000
Q Gao, G Tomlinson, S Das, S Cummings, L Sveen, J Fackenthal, P Schumm, O I Olopade. Hum Genet 2000
10
Factors associated with perceived risk of breast cancer among women attending a screening program.
S W Vernon, V G Vogel, S Halabi, M L Bondy. Breast Cancer Res Treat 1993
S W Vernon, V G Vogel, S Halabi, M L Bondy. Breast Cancer Res Treat 1993
12
Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age.
W C Black, R F Nease, A N Tosteson. J Natl Cancer Inst 1995
W C Black, R F Nease, A N Tosteson. J Natl Cancer Inst 1995
9
Relationships among breast cancer perceived absolute risk, comparative risk, and worries.
I M Lipkus, M Kuchibhatla, C M McBride, H B Bosworth, K I Pollak, I C Siegler, B K Rimer. Cancer Epidemiol Biomarkers Prev 2000
I M Lipkus, M Kuchibhatla, C M McBride, H B Bosworth, K I Pollak, I C Siegler, B K Rimer. Cancer Epidemiol Biomarkers Prev 2000
9
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
9
Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review.
Maria C Katapodi, Kathy A Lee, Noreen C Facione, Marylin J Dodd. Prev Med 2004
Maria C Katapodi, Kathy A Lee, Noreen C Facione, Marylin J Dodd. Prev Med 2004
9
Importance of psychological variables in understanding risk perceptions and breast cancer screening of African American women.
D Bowen, K M Hickman, D Powers. Womens Health 1997
D Bowen, K M Hickman, D Powers. Womens Health 1997
18
Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates.
R T Croyle, C Lerman. Prev Med 1993
R T Croyle, C Lerman. Prev Med 1993
8
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
8
Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
G Geller, T Doksum, B A Bernhardt, S A Metz. Cancer Epidemiol Biomarkers Prev 1999
G Geller, T Doksum, B A Bernhardt, S A Metz. Cancer Epidemiol Biomarkers Prev 1999
12
Perception of risk in women with a family history of breast cancer.
D G Evans, L D Burnell, P Hopwood, A Howell. Br J Cancer 1993
D G Evans, L D Burnell, P Hopwood, A Howell. Br J Cancer 1993
8
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
8
Sociocultural influences on participation in genetic risk assessment and testing among African American women.
Chanita Hughes, Grace Ann Fasaye, V Holland LaSalle, Clinton Finch. Patient Educ Couns 2003
Chanita Hughes, Grace Ann Fasaye, V Holland LaSalle, Clinton Finch. Patient Educ Couns 2003
10
Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Rita Nanda, L Philip Schumm, Shelly Cummings, James D Fackenthal, Lise Sveen, Foluso Ademuyiwa, Melody Cobleigh, Laura Esserman, Noralane M Lindor, Susan L Neuhausen,[...]. JAMA 2005
Rita Nanda, L Philip Schumm, Shelly Cummings, James D Fackenthal, Lise Sveen, Foluso Ademuyiwa, Melody Cobleigh, Laura Esserman, Noralane M Lindor, Susan L Neuhausen,[...]. JAMA 2005
8
Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Lina Jandorf, William Redd. Patient Educ Couns 2003
Hayley S Thompson, Heiddis B Valdimarsdottir, Lina Jandorf, William Redd. Patient Educ Couns 2003
8
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.